VEGFA and chronic kidney disease: Our study findings reveal that, although there was no significant association between baseline renal function (serum Cre levels and eGFR) and both visual and morphological outcomes in patients with DME undergoing anti-VEGF treatment, the presence of stage 3 or higher CKD at 36 months was significantly associated with greater fluctuations in CMT.